drugset / Trial / NCT01584453

Safety and Effectiveness of Intra-coronary Nitrite in Acute Myocardial Infarction

NCT01584453

RandomizedSingle-groupQuadruple-blindTreatment

Summary

Despite advances in the treatment of heart attacks the complications and death rates from failure of the heart to pump properly after treatment remain high. A heart attack occurs when one or more of the arteries that supply blood to the heart become blocked, causing the heart to be starved of oxygen and nutrients. This results in damage to the heart and so the the heart pumps less well. The main treatment for a heart attack is balloon treatment to open the blocked artery (called primary angioplasty). Whilst re-opening the artery is essential and allows blood to flow to the area of the heart starved of oxygen, this process also causes damage itself (called reperfusion injury) and increases the size of the heart attack further. Currently there are no treatments available that reduce this reperfusion injury. The investigators and others have shown that a substance called sodium nitrite reduces reperfusion injury in experimental models of a heart attack. The aim of this research is to perform a trial to investigate whether during a heart attack, an infusion of sodium nitrite into the damaged artery protects against reperfusion injury and reduces heart attack size in patients.

Timeline

Start
2012-04
Primary completion
2013-11
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Nitrite Small molecule 0.0018 mmol Other